Bristol Myers Squibb · Stock-Based Compensation

Latest reported$553.00Mperiod endingJun 30, 2026

BMY Stock-Based Comp ($0.00 → $553.00M)

Annual stock-based compensation

High-resolution chart · PNG

BMY stock-based compensation history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb Stock-Based Compensation — Annual fiscal periods (USD)
Period ending	Stock-Based Compensation (USD)
Dec 31, 2025	553,000,000
Dec 31, 2024	507,000,000
Dec 31, 2023	518,000,000
Dec 31, 2022	457,000,000
Dec 31, 2021	583,000,000
Dec 31, 2020	779,000,000
Dec 31, 2019	441,000,000
Dec 31, 2018	221,000,000
Dec 31, 2017	199,000,000
Dec 31, 2016	205,000,000
Dec 31, 2015	235,000,000
Dec 31, 2014	213,000,000
Dec 31, 2013	191,000,000
Dec 31, 2012	154,000,000
Dec 31, 2011	161,000,000
Dec 31, 2010	193,000,000
Dec 31, 2009	183,000,000
Dec 31, 2008	181,000,000
Dec 31, 2007	0
Dec 31, 2006	0
Dec 31, 2005	0
Dec 31, 2004	0
Dec 31, 2003	0
Dec 31, 2002	0
Dec 31, 2001	0
Dec 31, 2000	0
Dec 31, 1999	0
Dec 31, 1998	0
Dec 31, 1997	0
Dec 31, 1996	0
Dec 31, 1995	0
Dec 31, 1994	0
Dec 31, 1993	0
Dec 31, 1992	0
Dec 31, 1991	0
Dec 31, 1990	0
Dec 31, 1989	0